GB1056212A - Improved antacid composition and method for preparing the same - Google Patents

Improved antacid composition and method for preparing the same

Info

Publication number
GB1056212A
GB1056212A GB539065A GB539065A GB1056212A GB 1056212 A GB1056212 A GB 1056212A GB 539065 A GB539065 A GB 539065A GB 539065 A GB539065 A GB 539065A GB 1056212 A GB1056212 A GB 1056212A
Authority
GB
United Kingdom
Prior art keywords
preparing
same
antacid composition
parts
improved
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB539065A
Inventor
Bruno Puetzer
Leonard Mackles
Martin Perl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tintex Corp
Original Assignee
Tintex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tintex Corp filed Critical Tintex Corp
Priority to GB539065A priority Critical patent/GB1056212A/en
Publication of GB1056212A publication Critical patent/GB1056212A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

An antacid composition comprises from 15 to 40 parts by wt urea and 60 to 85 parts by wt. calcium carbonate, and optionally from 0 to 15 parts by wt. glycine. The antacids may be administered in liquid or solid form together with conventional excipients.
GB539065A 1965-02-08 1965-02-08 Improved antacid composition and method for preparing the same Expired GB1056212A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB539065A GB1056212A (en) 1965-02-08 1965-02-08 Improved antacid composition and method for preparing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB539065A GB1056212A (en) 1965-02-08 1965-02-08 Improved antacid composition and method for preparing the same

Publications (1)

Publication Number Publication Date
GB1056212A true GB1056212A (en) 1967-01-25

Family

ID=9795260

Family Applications (1)

Application Number Title Priority Date Filing Date
GB539065A Expired GB1056212A (en) 1965-02-08 1965-02-08 Improved antacid composition and method for preparing the same

Country Status (1)

Country Link
GB (1) GB1056212A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4446135A (en) * 1982-06-07 1984-05-01 Sterling Drug Inc. Chewable antacid tablets
WO1995010290A1 (en) * 1993-10-13 1995-04-20 Warner-Lambert Company Antacid pharmaceutical composition
US5762962A (en) * 1994-10-05 1998-06-09 Warner-Lambert Company Antacid pharmaceutical composition

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4446135A (en) * 1982-06-07 1984-05-01 Sterling Drug Inc. Chewable antacid tablets
WO1995010290A1 (en) * 1993-10-13 1995-04-20 Warner-Lambert Company Antacid pharmaceutical composition
US5762962A (en) * 1994-10-05 1998-06-09 Warner-Lambert Company Antacid pharmaceutical composition

Similar Documents

Publication Publication Date Title
AU3407871A (en) Improvements in or relating to injection lasers
GB1106003A (en) Improvements in or relating to combine harvesters
AU5353969A (en) Antacid composition
GB941410A (en) Improvements in or relating to automatically controlled sewing apparatus
GB1098802A (en) Loom
AU443154B2 (en) Concentrated liquid antacid compositions
GB1097102A (en) Improvements in or relating to combine harvesters
GB1056212A (en) Improved antacid composition and method for preparing the same
DK107182C (en) Process for the preparation of an oral, pharmaceutical magnesium hydroxide preparation in the form of an aqueous suspension with antacid and laxative properties.
ES351577A1 (en) Hydrocarbon and a process for the manufacture thereof
GB1117769A (en) Improvements in or relating to combine harvesters
GB1096139A (en) Improvements in or relating to harvesting machines
CA971879A (en) Concentrated antacid composition
CA955848A (en) Method for preserving antacid compositions
GB1082836A (en) Improvements in combine harvesters
Luce The Mississippi White Citizens Council: 1954-1959
Young The pastoral mode in Spanish drama before 1520
IL38094A0 (en) Selected 5-substituted-5-phenylalkyl barbituric acids,processes for preparing the same and therapeutic compositions containing the same
AU3307671A (en) Improvements in or relating to injection lasers
GB1021190A (en) Improvements in or relating to araliphatic carboxylic acids and the manufacture thereof
ZA703810B (en) Antacid composition
NL152231B (en) PROCEDURE FOR IMPROVING THE HARDNESS AND DURABILITY OF POROUS NATURAL STONE CONTAINING AT LEAST 10% W / W CALCIUM CARBONATE.
KAPLAN et al. Changes in the free radical/FR/ content in the organs of mice under conditions of hypo- and hyperoxia/Izmenenie soderzhaniia svobodnykh radikalov/SR/ v organakh myshei v usloviiakh gipo- i giperoksii/(Free radical content changes in mice organs under hyperoxia and hypoxia)
GB1094562A (en) Improvements in and relating to evaporation apparatus
Dzidic Mass spectrometric investigations of the hydration of alkali ions in the gas phase